Effect of Pecha Kucha-Based Education on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
The Effect of Education Provided Using the PechaKucha Method on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
1 other identifier
interventional
140
1 country
1
Brief Summary
This randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. Participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will receive individual education on symptom management during chemotherapy using the PechaKucha method. The education will be delivered as a video presentation consisting of 20 visual slides and lasting 6 minutes and 40 seconds. Participants in the control group will receive routine/standard patient education. Symptom severity and quality of life will be assessed before the education and one week after the intervention using the Edmonton Symptom Assessment System (ESAS) and the EQ-5D. The study will compare changes in symptom severity and quality of life between the intervention and control groups to determine whether PechaKucha-based education is effective in supporting symptom management and quality of life among patients receiving chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Jun 2026
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 3, 2026
CompletedFirst Submitted
Initial submission to the registry
August 13, 2026
CompletedFirst Posted
Study publicly available on registry
August 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
CompletedAugust 20, 2026
August 1, 2026
4 months
August 13, 2026
August 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Symptom Severity Assessed by the Edmonton Symptom Assessment System (ESAS)
The Edmonton Symptom Assessment System (ESAS) will be used to assess symptom severity in patients receiving chemotherapy. Participants rate the severity of each symptom on a numerical scale, with higher scores indicating greater symptom severity. The intervention group will receive symptom management education using the PechaKucha presentation format, whereas the control group will receive the same educational content using a conventional teaching method. Both groups will also receive a brochure summarizing the educational content. ESAS will be administered to both groups at baseline and one week after the intervention. Changes in symptom severity from baseline will be compared between the groups.
Baseline (before the intervention) and one week after the intervention
Study Arms (2)
PechaKucha-Based Education Group
EXPERIMENTALParticipants in this arm will receive individual education on "Symptom Management During Chemotherapy" delivered by the researchers using the PechaKucha method. The education will be provided as a video presentation consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds. The educational content covers pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia.
Routine/Standard Education Group
ACTIVE COMPARATORParticipants in this arm will receive routine/standard patient education provided as part of usual care in the chemotherapy unit. No PechaKucha-based education will be provided to participants in this group.
Interventions
The intervention consists of individual education on symptom management during chemotherapy delivered by the researchers using the PechaKucha method. The education is provided as a video presentation consisting of 20 visual slides, with each slide displayed for 20 seconds, for a total duration of 6 minutes and 40 seconds. The educational content addresses pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia.
Participants assigned to the control group will receive routine/standard patient education provided as part of usual care in the chemotherapy unit. This education does not include the PechaKucha-based symptom management education provided to the intervention group.
Eligibility Criteria
You may qualify if:
- Willing to participate in the study.
- Currently receiving treatment in the chemotherapy unit.
- Aged 18 years or older, willing to participate, and able to communicate effectively.
You may not qualify if:
- Being under 18 years of age.
- Having cognitive or communication difficulties.
- Having a visual or hearing impairment.
- Being in an advanced or terminal stage of the disease.
- Having a physical or psychological condition that prevents active participation in the educational process.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SBÜ Kanuni Sultan Süleyman E.A.H
Istanbul, 34520, Turkey (Türkiye)
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 13, 2026
First Posted
August 18, 2026
Study Start
June 3, 2026
Primary Completion
October 1, 2026
Study Completion
October 1, 2026
Last Updated
August 20, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data (IPD).